Evaluation of a multifaceted medication review in older patients in the outpatient setting: a before-and-after study.
80 and over
Aged–Aged
Drug Utilization Review
Frail Elderly
Polypharmacy
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
07
11
2022
accepted:
21
12
2022
medline:
1
5
2023
pubmed:
7
2
2023
entrez:
6
2
2023
Statut:
ppublish
Résumé
The prevalence of medication-related emergency department visits and acute hospital admissions in older patients is rising due to the ageing of the population and increasing prevalence of multimorbidity and associated polypharmacy. To explore whether a combined medication review performed in the outpatient setting reduces the number of medication-related emergency department visits and hospital (re)admissions. All consecutive patients visiting the geriatric outpatient clinic underwent a multifaceted medication review (i.e. evaluation by at least a geriatrician, and/or pharmacist and use of clinical decision support system). Subsequently, we analysed the number of, and reason for, emergency department visits, acute hospital admissions and readmissions in the year prior to and the year following the index-date (date of first presentation and medication review). A multifaceted medication review reduced the number of potentially medication-related emergency department visits (38.9% vs. 19.6%, p < 0.01), although the total number of ED visits or acute hospital admissions per patient in the year before and after medication review did not differ. A multifaceted medication review performed in the outpatient clinic reduced the number of potentially medication-related emergency department visits and could therefore reduce negative health outcomes and healthcare costs.
Sections du résumé
BACKGROUND
BACKGROUND
The prevalence of medication-related emergency department visits and acute hospital admissions in older patients is rising due to the ageing of the population and increasing prevalence of multimorbidity and associated polypharmacy.
AIM
OBJECTIVE
To explore whether a combined medication review performed in the outpatient setting reduces the number of medication-related emergency department visits and hospital (re)admissions.
METHOD
METHODS
All consecutive patients visiting the geriatric outpatient clinic underwent a multifaceted medication review (i.e. evaluation by at least a geriatrician, and/or pharmacist and use of clinical decision support system). Subsequently, we analysed the number of, and reason for, emergency department visits, acute hospital admissions and readmissions in the year prior to and the year following the index-date (date of first presentation and medication review).
RESULTS
RESULTS
A multifaceted medication review reduced the number of potentially medication-related emergency department visits (38.9% vs. 19.6%, p < 0.01), although the total number of ED visits or acute hospital admissions per patient in the year before and after medication review did not differ.
CONCLUSION
CONCLUSIONS
A multifaceted medication review performed in the outpatient clinic reduced the number of potentially medication-related emergency department visits and could therefore reduce negative health outcomes and healthcare costs.
Identifiants
pubmed: 36745311
doi: 10.1007/s11096-022-01531-3
pii: 10.1007/s11096-022-01531-3
pmc: PMC10147805
doi:
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
483-490Informations de copyright
© 2023. The Author(s).
Références
Ofori-Asenso R, Chin KL, Mazidi M, et al. Global incidence of Frailty and Prefrailty among Community-Dwelling older adults: a systematic review and Meta-analysis. JAMA Netw Open, 2019;2:2.
Pines JM, Mullins PM, Cooper JK, et al. National trends in emergency department use, care patterns, and quality of care of older adults in the United States. J Am Geriatr Soc. 2013;61:12–7.
doi: 10.1111/jgs.12072
pubmed: 23311549
Aminzadeh F, Dalziel WB. Older adults in the emergency department: a systematic review of patterns of use, adverse outcomes, and effectiveness of interventions. Ann Emerg Med. 2002;39:238–47.
doi: 10.1067/mem.2002.121523
pubmed: 11867975
Nymoen LD, Björk M, Flatebø TE, et al. Drug-related emergency department visits: prevalence and risk factors. Intern Emerg Med. 2022;17:1453–62.
doi: 10.1007/s11739-022-02935-9
pubmed: 35129789
pmcid: 9352618
Benard-Laribiere A, Miremont-Salamé G, Pérault-Pochatet MC. et al. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study. Fundam Clin Pharmacol. 2015;29:106–11.
doi: 10.1111/fcp.12088
pubmed: 24990220
Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.
doi: 10.1023/A:1015570104121
pubmed: 12061133
van der Hooft CS, Sturkenboom MC, van Grootheest K, et al. Adverse drug reaction-related hospitalisations: a nationwide study in the Netherlands. Drug Saf. 2006;29:161–8.
doi: 10.2165/00002018-200629020-00006
pubmed: 16454543
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.
doi: 10.1136/bmj.329.7456.15
pubmed: 15231615
pmcid: 443443
Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57:121–6.
Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of older person’s prescriptions) and START (Screening Tool to Alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.
doi: 10.5414/CPP46072
pubmed: 18218287
Khalil H, Bell B, Chambers H, et al. Professional, structural and organisational interventions in primary care for reducing medication errors. Cochrane Database Syst Rev. 2017;10:CD003942.
pubmed: 28977687
Dautzenberg L, Bretagne L, Koek HL, et al. Medication review interventions to reduce hospital readmissions in older people. J Am Geriatr Soc. 2021;69:1646–58.
doi: 10.1111/jgs.17041
pubmed: 33576506
pmcid: 8247962
Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev, 2016. 2:CD008986.
Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65:303–16.
doi: 10.1111/j.1365-2125.2007.03071.x
pubmed: 18093253
Royal S, Smeaton L, Avery AJ, et al. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006;15:23–31.
doi: 10.1136/qshc.2004.012153
pubmed: 16456206
pmcid: 2563996
Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6:e010003.
doi: 10.1136/bmjopen-2015-010003
pubmed: 26908524
pmcid: 4769405
WHO. Guidelines for ATC classification and DDD assignment 2012 in World Health Organisation. https://www.whocc.no/filearchive/publications/2022_guidelines_web.pdf ; 2022. Accessed 17-12-2022.
Dutch General Practitioners Association (NHG), D.A.f.C.G.N., Order of Medical Specialists (OMS), Multidisciplinary Guideline Polypharmacy in the elderly https://richtlijnen.nhg.org/multidisciplinaire-richtlijnen/polyfarmacie-bij-ouderen ; 2020. Accessed 17 Dec 2022.
Hurkens KPGM, Mestres-Gonzalvo C, de Wit HAJM, et al. Assessing the strengths and weaknesses of a computer assisted medication review in hospitalized patients. Int J Hosp Pharm. 2017;2:1–12.
doi: 10.28933/IJHP-2017-10-0101
Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician’s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140:795–801.
doi: 10.7326/0003-4819-140-10-200405180-00009
pubmed: 15148066
Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment)--an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36:632–8.
doi: 10.1093/ageing/afm118
pubmed: 17881418
Zwietering NA, Westra D, Winkens B, et al. Medication in older patients reviewed multiple ways (MORE) study. Int J Clin Pharm. 2019;41:1262–71.
Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123–33.
doi: 10.1016/j.jacc.2013.11.053
pubmed: 24491689
Zhao Y, Kuo TC, Weier S, et al. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer’s. BMC Health Serv Res. 2008;8:108.
doi: 10.1186/1472-6963-8-108
pubmed: 18498638
pmcid: 2424046
Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.
pubmed: 18809816
Saedder EA, Brock B, Nielsen LP, et al. Identifying high-risk medication: a systematic literature review. Eur J Clin Pharmacol. 2014;70:637–45.
doi: 10.1007/s00228-014-1668-z
pubmed: 24671697
Warle-van Herwaarden MF, Kramers C, Sturkenboom MC, et al. Targeting outpatient drug safety: recommendations of the dutch HARM-wrestling task force. Drug Saf. 2012;35:245–59.
doi: 10.2165/11596000-000000000-00000
pubmed: 22339574
Saedder EA, Lisby M, Nielsen LP, et al. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80:808–17.
doi: 10.1111/bcp.12600
pubmed: 25677107
pmcid: 4594723
Huiskes VJ, Burger DM, van den Ende CHM, et al. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017;18:5.
doi: 10.1186/s12875-016-0577-x
pubmed: 28095780
pmcid: 5240219
Renaudin P, Boyer L, Esteve MA, et al. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82:1660–73.
doi: 10.1111/bcp.13085
pubmed: 27511835
pmcid: 5099542
Ravn-Nielsen LV, Duckert ML, Lund ML, et al. Effect of an In-Hospital multifaceted clinical pharmacist intervention on the risk of readmission: a Randomized Clinical Trial. JAMA Intern Med. 2018;178:375–82.
doi: 10.1001/jamainternmed.2017.8274
pubmed: 29379953
pmcid: 5885912